Federated Hermes Inc. Sells 7,592 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Federated Hermes Inc. lowered its position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 23.2% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 25,073 shares of the real estate investment trust’s stock after selling 7,592 shares during the quarter. Federated Hermes Inc.’s holdings in Sabra Health Care REIT were worth $358,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of SBRA. GraniteShares Advisors LLC bought a new stake in Sabra Health Care REIT during the fourth quarter worth $1,455,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Sabra Health Care REIT by 4.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 89,060 shares of the real estate investment trust’s stock worth $1,271,000 after buying an additional 3,633 shares during the last quarter. Mackenzie Financial Corp grew its position in Sabra Health Care REIT by 113.3% during the fourth quarter. Mackenzie Financial Corp now owns 32,483 shares of the real estate investment trust’s stock valued at $464,000 after buying an additional 17,256 shares during the period. Strs Ohio increased its holdings in Sabra Health Care REIT by 104.1% during the fourth quarter. Strs Ohio now owns 100,000 shares of the real estate investment trust’s stock worth $1,427,000 after buying an additional 51,000 shares during the last quarter. Finally, Louisiana State Employees Retirement System bought a new stake in Sabra Health Care REIT in the fourth quarter worth about $926,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Health Care REIT Stock Up 0.9 %

SBRA stock opened at $14.35 on Friday. Sabra Health Care REIT, Inc. has a twelve month low of $10.30 and a twelve month high of $14.91. The firm has a market capitalization of $3.32 billion, a PE ratio of 287.00, a PEG ratio of 5.11 and a beta of 1.17. The company has a quick ratio of 3.41, a current ratio of 3.41 and a debt-to-equity ratio of 0.86. The stock has a 50-day simple moving average of $14.09 and a two-hundred day simple moving average of $14.03.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on SBRA. Wedbush reissued an “outperform” rating and set a $17.00 target price on shares of Sabra Health Care REIT in a research report on Thursday, February 29th. Deutsche Bank Aktiengesellschaft started coverage on Sabra Health Care REIT in a research report on Tuesday, January 30th. They issued a “buy” rating and a $21.00 target price for the company. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $15.77.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.